narcolepsy-treatment Breakthrough Narcolepsy Treatment Receives FDA Fast Track Designation FDA grants Breakthrough Therapy designation to novel narcolepsy treatment targeting orexin receptors, offering hope beyond symptom management for 200,000+ patients.
